![](https://investorshub.advfn.com/uicon/591374.png?cb=1485035485)
Monday, February 27, 2017 10:44:30 PM
The more I do DD on biotech companies the more I see clinical studies OUTSIDE of the US. I see medicines available to people in Europe, Asia and South America but not in the US.
IMHO $OWCP has done the right thing with the psoriasis cream. IRB Helsinki protocol safety studies are a very reputable standard and will allow the cream to be sold in many countries outside of the US. Yes, the US market is very affluent, but disorders like psoriasis are more common in colder climates like Canada and Scandinavia and Eastern Europe.
Know What You Own. My posts should not be construed as investment advice.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM